# SARS-CoV-2
Live literature review on our current knowledge about the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).<br>
This page will be updated as new papers will be published.<br>
The idea is to have a clear, essential, unbiased, rigorous and simple collection of information from primary sources for both the scientific community and the general public.

If you would like to contribute to the project, send improvements or corrections write an email to <simone.monachino@studenti.unitn.it>

Note: The date (yy/mm/dd) specifies when the article was posted and its link redirects to the DOI of the paper.<br>
NPR means "Not Peer Reviewed".

## Basic Reproduction Number (R0)
- ``Range = 2.24 - 3.58`` [20/03/01](https://doi.org/10.1016/j.ijid.2020.01.050)
- ``Range = 2.47 – 2.86`` [20/02/29](https://doi.org/10.1016/S0140-6736(20)30260-9)

## Incubation Period
- ``Range = 2.0 - 7.00 days. Median = 4 days (n = 291)`` [20/02/28](https://doi/10.1056/NEJMoa2002032)
- ``Range = 2.0 - 14.0 days. Mean = 5.6 days (n = 158)`` [20/02/17](https://doi.org/10.3390/jcm9020538)
- ``Range = 2.1 - 11.1 days. Mean = 6.4 days (n = 088)`` [20/02/06](https://doi.org/10.2807/1560-7917.ES.2020.25.5.2000062)
- ``Range = 4.1 - 7.00 days. Mean = 5.2 days (n = 425)`` [20/01/29](https://doi.org/10.1056/NEJMoa2001316)

## Detected presence in Aerosol (airborne transmissibility)
- ``Yes (Up to 3 Hours. Half-life = 1.1 hours)`` [20/03/17](https://doi.org/10.1101/2020.03.09.20033217) (NPR)
- ``Yes`` [20/03/10](https://doi.org/10.1101/2020.03.08.982637) (NPR)
- ``No`` [20/03/04](https://doi.org/10.1001/jama.2020.3227)

## Viral Shedding
- ``Range = 8 - 37 Days. Median: 20 Days. (n = 137)`` [20/03/11](https://doi.org/10.1016/S0140-6736(20)30566-3)
- ``Range = 12 - 32 Days (n = 4)`` [20/02/27](https://doi.org/10.1001/jama.2020.2783)

## Observed possibility of Reinfection
- ``No (in Macaca mulatta)`` [20/03/14](https://doi.org/10.1101/2020.03.13.990226) (NPR)

## Observed positive test results in patients recovered from COVID-19 after resulting negative
- ``Yes (RT-PCR)`` [20/03/14](https://doi.org/10.1101/2020.03.13.990226)
- ``Yes (Stool) `` [20/03/14](https://doi.org/10.1053/j.gastro.2020.02.055)

## Case Fatality Rate (CFR) estimates
- ``Range: 0.25 % – 3.00 %`` [20/03/13](https://doi.org/10.3201/eid2606.200320)
- ``2.3 %``[20/02/29](https://doi.org/10.3855/jidc.12600)
- ``2.3 %``[20/02/24](https://doi.org/10.1001/jama.2020.2648)

## Asymptomatic transmission (now widely recognized in the scientific community)
- ``Yes`` [20/03/19](https://doi.org/10.1056/NEJMc2001737)

## Classification
- ``Superkingdom:`` Viruses
- ``Realm:`` Riboviria
- ``Order:`` Nidovirales
- ``Suborder:`` Cornidovirineae
- ``Family:`` Coronaviridae
- ``Subfamily:`` Orthocoronavirinae
- ``Genus:`` Betacoronavirus
- ``Subgenus:`` Sarbecovirus
- ``Species:`` Severe acute respiratory syndrome-related coronavirus
- ``Strain:``	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- ``Synonyms:`` HCoV-19, 2019-nCoV, SARS2, COVID-19 virus, Wuhan coronavirus, Human coronavirus 2019

[Lineage Source](https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=2697049)

## Genome
- Size: ``29903 bp`` [20/01/17](https://www.ncbi.nlm.nih.gov/nuccore/MN908947)
- Full sequence: [20/01/17](https://www.ncbi.nlm.nih.gov/nuccore/MN908947.3?report=fasta)

## Potential Seasonal Behavior
- ``No`` [20/03/12](https://dx.doi.org/10.2139/ssrn.3552677)

## Clinical trials of investigational vaccine for COVID-19
- ``mRNA-1273`` [Start: 3 March 2020 - Estimated Completion: 1 June 2021](https://clinicaltrials.gov/ct2/show/NCT04283461)
- ``LV-SMENP`` [Start: 24 March 2020 - Estimated Completion: 31 December 2024](https://clinicaltrials.gov/ct2/show/NCT04276896)
- ``aAPC`` [Start: 15 February 2020 - Estimated Completion: 31 December 2024](https://clinicaltrials.gov/ct2/show/NCT04299724)
